Medpace Holdings, Inc. (MEDP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

392.57

+1.50

(+0.38%)

At close: 04:00PM EDT

392.57

0.00

(0.00%)

After hours:

05:05PM EDT

Major Holders

Insider Roster

Insider Transactions

Currency in USD

Insider Purchases Last 6 Months	Shares	Trans
Purchases	60,957	13
Sales	2,421,402	36
Net Shares Purchased (Sold)	-2,360,445	49
Total Insider Shares Held	5.6M	N/A
% Net Shares Purchased (Sold)	-29.70%	N/A

Net Institutional Purchases Prior Quarter to Latest Quarter	Shares
Net Shares Purchased (Sold)	N/A
% Change in Institutional Shares Held	N/A

Insider Transactions Reported - Last Two Years

Insider	Transaction	Type	Value	Date	Shares
TROENDLE AUGUST J Chief Executive Officer	Sale at price 400.31 - 400.69 per share.	Direct	6,782,987	Apr 30, 2024	16,930
KRAFT ROBERT O Director		Direct		Mar 28, 2024	72
CARLEY BRIAN T Director		Direct		Mar 28, 2024	79
MCCARTHY CORNELIUS P. III Director		Direct		Mar 28, 2024	63
BURWIG SUSAN ELIZABETH Officer	Sale at price 403.00 per share.	Direct	41,106	Mar 15, 2024	102
KEATING ASHLEY M. Director	Sale at price 409.87 per share.	Direct	102,468	Mar 14, 2024	250
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 84.36 per share.	Direct	42,180	Mar 14, 2024	500
TROENDLE AUGUST J Chief Executive Officer	Sale at price 408.71 - 412.98 per share.	Indirect	82,321,250	Mar 08, 2024	200,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 408.71 - 412.98 per share.	Direct	82,321,250	Mar 08, 2024	200,000
KEATING ASHLEY M. Director	Sale at price 415.00 per share.	Direct	195,880	Mar 07, 2024	472
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	25,955	Mar 07, 2024	472
TROENDLE AUGUST J Chief Executive Officer	Sale at price 402.70 - 403.12 per share.	Indirect	40,291,000	Mar 05, 2024	100,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 402.70 - 403.12 per share.	Direct	40,291,000	Mar 05, 2024	100,000
GEIGER JESSE J President	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	3,626,000	Mar 05, 2024	40,000
GEIGER JESSE J President	Sale at price 403.03 per share.	Direct	8,996,033	Mar 04, 2024	22,321
TROENDLE AUGUST J Chief Executive Officer	Sale at price 393.71 - 401.88 per share.	Indirect	40,024,600	Mar 01, 2024	100,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 393.71 - 401.88 per share.	Direct	40,024,600	Mar 01, 2024	100,000
EWALD STEPHEN P General Counsel	Sale at price 393.50 - 400.79 per share.	Direct	597,923	Mar 01, 2024	1,513
GEIGER JESSE J President	Sale at price 393.50 per share.	Direct	1,006,586	Feb 29, 2024	2,558
TROENDLE AUGUST J Chief Executive Officer	Sale at price 401.88 - 404.13 per share.	Indirect	40,300,500	Feb 28, 2024	100,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 401.88 - 404.13 per share.	Direct	40,300,500	Feb 28, 2024	100,000
KEATING ASHLEY M. Director	Sale at price 405.00 per share.	Direct	202,500	Feb 28, 2024	500
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	27,495	Feb 28, 2024	500
TROENDLE AUGUST J Chief Executive Officer	Sale at price 400.32 - 402.38 per share.	Indirect	62,938,689	Feb 26, 2024	156,928
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 400.32 - 402.38 per share.	Direct	62,938,689	Feb 26, 2024	156,928
KEATING ASHLEY M. Director	Sale at price 403.89 - 404.68 per share.	Direct	202,147	Feb 26, 2024	500
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	27,495	Feb 26, 2024	500
TROENDLE AUGUST J Chief Executive Officer	Sale at price 383.44 - 395.98 per share.	Indirect	53,406,441	Feb 22, 2024	136,012
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 383.44 - 395.98 per share.	Direct	53,406,441	Feb 22, 2024	136,012
TROENDLE AUGUST J Chief Executive Officer	Sale at price 386.39 - 391.75 per share.	Indirect	24,992,323	Feb 20, 2024	63,988
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 386.39 - 391.75 per share.	Indirect	24,992,323	Feb 20, 2024	63,988
CARLEY BRIAN T Director	Conversion of Exercise of derivative security at price 26.44 per share.	Direct	364,396	Feb 20, 2024	13,782
MCCARTHY CORNELIUS P. III Director	Conversion of Exercise of derivative security at price 57.17 per share.	Direct	269,271	Feb 08, 2024	4,710
KRAFT ROBERT O Director		Direct		Dec 29, 2023	94
CARLEY BRIAN T Director		Direct		Dec 29, 2023	103
MCCARTHY CORNELIUS P. III Director		Direct		Dec 29, 2023	82
BURWIG SUSAN ELIZABETH Officer	Sale at price 303.00 - 304.15 per share.	Direct	3,769,150	Dec 15, 2023	12,400
TROENDLE AUGUST J Chief Executive Officer	Sale at price 272.18 - 273.26 per share.	Indirect	14,507,101	Dec 01, 2023	53,167
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 272.18 - 273.26 per share.	Direct	14,507,101	Dec 01, 2023	53,167
TROENDLE AUGUST J Chief Executive Officer	Sale at price 273.66 - 276.10 per share.	Indirect	12,877,319	Nov 28, 2023	46,833
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 273.66 - 276.10 per share.	Direct	12,877,319	Nov 28, 2023	46,833
TROENDLE AUGUST J Chief Executive Officer	Sale at price 277.81 per share.	Indirect	6,945,250	Nov 22, 2023	25,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 277.81 per share.	Direct	6,945,250	Nov 22, 2023	25,000
TROENDLE AUGUST J Chief Executive Officer	Sale at price 277.37 per share.	Indirect	6,934,250	Nov 21, 2023	25,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 277.37 per share.	Direct	6,934,250	Nov 21, 2023	25,000
TROENDLE AUGUST J Chief Executive Officer	Sale at price 273.91 - 275.45 per share.	Indirect	27,468,000	Nov 20, 2023	100,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 273.91 - 275.45 per share.	Direct	27,468,000	Nov 20, 2023	100,000
TROENDLE AUGUST J Chief Executive Officer	Sale at price 281.61 - 283.42 per share.	Indirect	21,217,980	Nov 16, 2023	75,000
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 281.61 - 283.42 per share.	Direct	21,217,980	Nov 16, 2023	75,000
BURWIG SUSAN ELIZABETH Officer	Conversion of Exercise of derivative security at price 32.05 per share.	Direct	240,375	Oct 23, 2023	7,500
KRAFT ROBERT O Director		Direct		Sept 29, 2023	94
CARLEY BRIAN T Director		Direct		Sept 29, 2023	103
MCCARTHY CORNELIUS P. III Director		Direct		Sept 29, 2023	82
TROENDLE AUGUST J Chief Executive Officer	Sale at price 244.27 - 255.48 per share.	Indirect	31,833,495	Sept 21, 2023	127,308
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 244.27 - 255.48 per share.	Direct	31,833,495	Sept 21, 2023	127,308
TROENDLE AUGUST J Chief Executive Officer	Sale at price 259.66 - 274.76 per share.	Indirect	50,339,894	Sept 19, 2023	190,764
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 259.66 - 274.76 per share.	Direct	50,339,894	Sept 19, 2023	190,764
KRAFT ROBERT O Director	Sale at price 265.67 per share.	Direct	3,661,464	Aug 14, 2023	13,782
KRAFT ROBERT O Director	Conversion of Exercise of derivative security at price 26.44 per share.	Direct	364,396	Aug 14, 2023	13,782
BRADY KEVIN M. Chief Financial Officer	Sale at price 255.00 per share.	Direct	1,785,000	Jul 31, 2023	7,000
BRADY KEVIN M. Chief Financial Officer	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	906,500	Jul 31, 2023	10,000
EWALD STEPHEN P General Counsel	Sale at price 254.39 per share.	Direct	5,558,422	Jul 27, 2023	21,850
EWALD STEPHEN P General Counsel	Conversion of Exercise of derivative security at price 107.93 per share.	Direct	2,358,270	Jul 27, 2023	21,850
KRAFT ROBERT O Director		Direct		Jun 30, 2023	94
CARLEY BRIAN T Director		Direct		Jun 30, 2023	103
MCCARTHY CORNELIUS P. III Director		Direct		Jun 30, 2023	82
CARLEY BRIAN T Director	Conversion of Exercise of derivative security at price 23.00 per share.	Direct	170,200	Jun 15, 2023	7,400
TROENDLE AUGUST J Chief Executive Officer	Sale at price 220.85 per share.	Indirect	10,898,285	Jun 08, 2023	49,347
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 220.85 per share.	Direct	10,898,285	Jun 08, 2023	49,347
TROENDLE AUGUST J Chief Executive Officer	Sale at price 220.46 - 223.05 per share.	Indirect	37,544,581	Jun 07, 2023	169,005
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 220.46 - 223.05 per share.	Direct	37,544,581	Jun 07, 2023	169,005
TROENDLE AUGUST J Chief Executive Officer	Sale at price 221.83 per share.	Indirect	7,020,476	Apr 25, 2023	31,648
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 221.83 per share.	Direct	7,020,476	Apr 25, 2023	31,648
KRAFT ROBERT O Director		Direct		Mar 31, 2023	94
CARLEY BRIAN T Director		Direct		Mar 31, 2023	104
MCCARTHY CORNELIUS P. III Director		Direct		Mar 31, 2023	82
BRADY KEVIN M. Chief Financial Officer	Sale at price 227.09 - 229.30 per share.	Direct	457,840	Nov 16, 2022	2,000
GEIGER JESSE J President	Sale at price 230.00 per share.	Direct	1,610,000	Nov 15, 2022	7,000
GEIGER JESSE J President	Conversion of Exercise of derivative security at price 28.32 per share.	Direct	198,240	Nov 15, 2022	7,000
KRAFT ROBERT O Director	Sale at price 221.42 per share.	Direct	2,132,275	Nov 01, 2022	9,630
KRAFT ROBERT O Director	Conversion of Exercise of derivative security at price 23.00 per share.	Direct	221,490	Nov 01, 2022	9,630
EWALD STEPHEN P General Counsel	Sale at price 220.53 per share.	Direct	1,433,445	Oct 27, 2022	6,500
EWALD STEPHEN P General Counsel	Conversion of Exercise of derivative security at price 32.05 per share.	Direct	208,325	Oct 27, 2022	6,500
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 154.59 per share.	Indirect	8,877,485	Sept 22, 2022	57,426
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 154.59 per share.	Direct	8,877,485	Sept 22, 2022	57,426
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 155.14 - 161.63 per share.	Indirect	29,814,076	Sept 21, 2022	188,238
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 155.14 - 161.63 per share.	Direct	29,814,076	Sept 21, 2022	188,238
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 149.58 - 153.48 per share.	Indirect	23,796,527	Sept 19, 2022	156,635
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 149.58 - 153.48 per share.	Direct	23,796,527	Sept 19, 2022	156,635
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 152.66 - 153.11 per share.	Indirect	19,115,517	Sept 15, 2022	125,032
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 152.66 - 153.11 per share.	Direct	19,115,517	Sept 15, 2022	125,032
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 157.12 - 167.58 per share.	Indirect	20,298,778	Sept 13, 2022	125,031
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 157.12 - 167.58 per share.	Direct	20,298,778	Sept 13, 2022	125,031
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 157.65 - 164.33 per share.	Indirect	18,210,223	Sept 09, 2022	113,114
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 157.65 - 164.33 per share.	Direct	18,210,223	Sept 09, 2022	113,114
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 147.59 - 150.72 per share.	Indirect	16,871,519	Sept 07, 2022	113,114
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 147.59 - 150.72 per share.	Direct	16,871,519	Sept 07, 2022	113,114
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 144.52 - 144.98 per share.	Indirect	13,143,379	Sept 02, 2022	90,790
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 144.52 - 144.98 per share.	Direct	13,143,379	Sept 02, 2022	90,790
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 145.00 per share.	Indirect	1,207,850	Jul 18, 2022	8,330
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 145.00 per share.	Direct	1,207,850	Jul 18, 2022	8,330
TROENDLE AUGUST J Chief Executive Officer	Purchase at price 144.59 per share.	Indirect	3,222,911	Jul 14, 2022	22,290
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 144.59 per share.	Direct	3,222,911	Jul 14, 2022	22,290
EWALD STEPHEN P General Counsel	Conversion of Exercise of derivative security at price 32.05 per share.	Direct	32,050	May 06, 2022	1,000
TROENDLE AUGUST J Chief Executive Officer	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	9,065,000	Mar 01, 2022	100,000
BURWIG SUSAN ELIZABETH Officer	Conversion of Exercise of derivative security at price 28.32 per share.	Direct	351,168	Feb 23, 2022	12,400
DAVENPORT FRED B JR Director	Purchase at price 145.80 per share.	Indirect	72,900	Feb 17, 2022	500
TROENDLE AUGUST J Chief Executive Officer	Sale at price 213.44 per share.	Indirect	712,463	Jan 04, 2022	3,338
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 213.44 per share.	Direct	712,463	Jan 04, 2022	3,338
TROENDLE AUGUST J Chief Executive Officer	Sale at price 212.70 - 220.34 per share.	Indirect	10,892,117	Jan 03, 2022	50,189
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 212.70 - 220.34 per share.	Direct	10,892,117	Jan 03, 2022	50,189
TROENDLE AUGUST J Chief Executive Officer	Sale at price 220.16 - 222.18 per share.	Indirect	9,046,217	Dec 29, 2021	40,868
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 220.16 - 222.18 per share.	Direct	9,046,217	Dec 29, 2021	40,868
TROENDLE AUGUST J Chief Executive Officer	Sale at price 223.19 - 226.11 per share.	Indirect	13,952,383	Dec 27, 2021	62,001
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 223.19 - 226.11 per share.	Direct	13,952,383	Dec 27, 2021	62,001
TROENDLE AUGUST J Chief Executive Officer	Sale at price 215.17 - 220.50 per share.	Indirect	12,492,358	Dec 22, 2021	57,093
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 215.17 - 220.50 per share.	Direct	12,492,358	Dec 22, 2021	57,093
TROENDLE AUGUST J Chief Executive Officer	Sale at price 212.57 - 213.59 per share.	Indirect	11,369,488	Dec 20, 2021	53,339
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 212.57 - 213.59 per share.	Direct	11,369,488	Dec 20, 2021	53,339
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.22 - 210.28 per share.	Indirect	1,762,420	Dec 16, 2021	8,383
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.22 - 210.28 per share.	Direct	1,762,420	Dec 16, 2021	8,383
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.20 - 212.13 per share.	Indirect	3,245,629	Dec 10, 2021	15,303
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.20 - 212.13 per share.	Direct	3,245,629	Dec 10, 2021	15,303
TROENDLE AUGUST J Chief Executive Officer	Sale at price 211.78 - 212.89 per share.	Indirect	7,300,943	Dec 08, 2021	34,391
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 211.78 - 212.89 per share.	Direct	7,300,943	Dec 08, 2021	34,391
TROENDLE AUGUST J Chief Executive Officer	Sale at price 211.48 per share.	Indirect	84,592	Dec 03, 2021	400
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 211.48 per share.	Direct	84,592	Dec 03, 2021	400
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.79 - 211.57 per share.	Indirect	6,920,359	Dec 02, 2021	32,732
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.79 - 211.57 per share.	Direct	6,920,359	Dec 02, 2021	32,732
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.29 - 212.10 per share.	Indirect	2,611,019	Nov 30, 2021	12,312
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.29 - 212.10 per share.	Direct	2,611,019	Nov 30, 2021	12,312
TROENDLE AUGUST J Chief Executive Officer	Sale at price 210.99 - 213.26 per share.	Indirect	6,288,735	Nov 26, 2021	29,649
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 210.99 - 213.26 per share.	Direct	6,288,735	Nov 26, 2021	29,649
TROENDLE AUGUST J Chief Executive Officer	Sale at price 212.64 - 224.33 per share.	Indirect	16,337,315	Nov 23, 2021	74,185
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 212.64 - 224.33 per share.	Direct	16,337,315	Nov 23, 2021	74,185
KING THOMAS C. Director	Sale at price 226.63 per share.	Direct	39,887	Nov 03, 2021	176
KING THOMAS C. Director	Conversion of Exercise of derivative security at price 75.63 per share.	Direct	37,815	Nov 03, 2021	500
BRADY KEVIN M. Chief Financial Officer	Sale at price 226.50 per share.	Direct	283,125	Nov 02, 2021	1,250
BRADY KEVIN M. Chief Financial Officer	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	113,312	Nov 02, 2021	1,250
EWALD STEPHEN P General Counsel	Sale at price 209.13 per share.	Direct	2,091,300	Oct 26, 2021	10,000
EWALD STEPHEN P General Counsel	Conversion of Exercise of derivative security at price 90.65 per share.	Direct	906,500	Oct 26, 2021	10,000
GEIGER JESSE J President	Sale at price 211.36 per share.	Direct	2,113,600	Oct 26, 2021	10,000
GEIGER JESSE J President	Conversion of Exercise of derivative security at price 28.32 per share.	Direct	283,200	Oct 26, 2021	10,000
KEATING ASHLEY M. Director	Sale at price 210.00 per share.	Direct	420,000	Oct 26, 2021	2,000
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	109,980	Oct 26, 2021	2,000
TROENDLE AUGUST J Chief Executive Officer	Sale at price 191.82 - 191.85 per share.	Indirect	5,916,252	Sept 03, 2021	30,838
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 191.82 - 191.85 per share.	Direct	5,916,252	Sept 03, 2021	30,838
BURWIG SUSAN ELIZABETH Officer	Sale at price 192.16 - 192.67 per share.	Direct	11,960,244	Sept 03, 2021	62,222
KEATING ASHLEY M. Director	Sale at price 195.00 per share.	Direct	390,000	Sept 03, 2021	2,000
KEATING ASHLEY M. Director	Conversion of Exercise of derivative security at price 54.99 per share.	Direct	109,980	Sept 03, 2021	2,000

S&P/TSX21,947.41+124.19(+0.57%)

S&P 5005,127.79+63.59(+1.26%)

DOW38,675.68+450.02(+1.18%)

CAD/USD0.7308-0.0006(-0.08%)

CRUDE OIL77.99-0.96(-1.22%)

Bitcoin CAD87,309.27+880.43(+1.02%)

Medpace Holdings, Inc. (MEDP)

Insider Transactions

Insider Transactions Reported - Last Two Years

S&P/TSX
21,947.41
+124.19(+0.57%)

S&P 500
5,127.79
+63.59(+1.26%)

DOW
38,675.68
+450.02(+1.18%)

CAD/USD
0.7308
-0.0006(-0.08%)

CRUDE OIL
77.99
-0.96(-1.22%)

Bitcoin CAD
87,309.27
+880.43(+1.02%)